← Back to Clinical Trials
RecruitingNCT06183528

Effects of Pericapsular Nerve Group Block on Postoperative Recovery for Total Hip Arthroplasty

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionAnalgesia
SponsorUmraniye Education and Research Hospital
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment60
SexALL
Min Age40 Years
Max Age85 Years
Start Date2023-09-01
Completion2024-10-10
Interventions
Pericapsular Nerve Group (PENG) Block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The hypothesis of this study is that patients who undergo PENG block in before Total Hip Artroplasthy (THA) surgery with spinal anesthesia will have reduced postoperative pain scores, less need for opioid analgesics and earlier mobilisation.

Eligibility Criteria

Inclusion Criteria: * THA performed by posterior approach * 40-85 age range * ASA 1-3 Exclusion Criteria: Under 40 years of age, over 85 years of age, * ASA 4 and above, * Cognitive impairment (Alzheimer's disease, dementia, delirium etc.), * Hip fracture, * Application site infection, * Allergy to local anaesthetic agents, * Patients are non-consenting patients.

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE ANALGESIA TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology